View in EDS HTML Full Text PDF Full Text

Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy.

Saved in:
Bibliographic Details
Title: Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy.
Authors: Ittershagen S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. stacie.ittershagen@novartis.com., Ericson S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Eldjerou L; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Shojaee A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Bleickardt E; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Patel M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Taran T; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Anak O; Novartis Pharma AG, Basel, Switzerland., Hall C; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Leung M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Roccoberton D; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Salmon F; Novartis Pharma AG, Basel, Switzerland., Fuchs M; Novartis Pharma AG, Basel, Switzerland., Romanov V; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Lebwohl D; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Source: Current hematologic malignancy reports [Curr Hematol Malig Rep] 2019 Feb; Vol. 14 (1), pp. 47-55.
Publication Type: Journal Article; Review
Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 101262565 Publication Model: Print Cited Medium: Internet ISSN: 1558-822X (Electronic) Linking ISSN: 15588211 NLM ISO Abbreviation: Curr Hematol Malig Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30666506
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ittershagen+S%22">Ittershagen S</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. stacie.ittershagen@novartis.com.<br /><searchLink fieldCode="AU" term="%22Ericson+S%22">Ericson S</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Eldjerou+L%22">Eldjerou L</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Shojaee+A%22">Shojaee A</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Bleickardt+E%22">Bleickardt E</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Patel+M%22">Patel M</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Taran+T%22">Taran T</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Anak+O%22">Anak O</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hall+C%22">Hall C</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Leung+M%22">Leung M</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Roccoberton+D%22">Roccoberton D</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Salmon+F%22">Salmon F</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fuchs+M%22">Fuchs M</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Romanov+V%22">Romanov V</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lebwohl+D%22">Lebwohl D</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101262565%22">Current hematologic malignancy reports</searchLink> [Curr Hematol Malig Rep] 2019 Feb; Vol. 14 (1), pp. 47-55.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Current+Science%22">Current Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101262565 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-822X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215588211%22">15588211 </searchLink><i>NLM ISO Abbreviation: </i>Curr Hematol Malig Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30666506
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11899-019-0498-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 47
    Titles:
      – TitleFull: Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ittershagen S
      – PersonEntity:
          Name:
            NameFull: Ericson S
      – PersonEntity:
          Name:
            NameFull: Eldjerou L
      – PersonEntity:
          Name:
            NameFull: Shojaee A
      – PersonEntity:
          Name:
            NameFull: Bleickardt E
      – PersonEntity:
          Name:
            NameFull: Patel M
      – PersonEntity:
          Name:
            NameFull: Taran T
      – PersonEntity:
          Name:
            NameFull: Anak O
      – PersonEntity:
          Name:
            NameFull: Hall C
      – PersonEntity:
          Name:
            NameFull: Leung M
      – PersonEntity:
          Name:
            NameFull: Roccoberton D
      – PersonEntity:
          Name:
            NameFull: Salmon F
      – PersonEntity:
          Name:
            NameFull: Fuchs M
      – PersonEntity:
          Name:
            NameFull: Romanov V
      – PersonEntity:
          Name:
            NameFull: Lebwohl D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2019 Feb
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1558-822X
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Current hematologic malignancy reports
              Type: main
ResultId 1